Clinical trial
Control of COVID-19 Outbreaks in Long Term Care (CONTROL-COVID)
NCT04448119 is registered in ClinicalTrials.gov with Appili Therapeutics Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Control of COVID-19 Outbreaks in Long Term Care (CONTROL-COVID)
- Lead sponsor
- Appili Therapeutics Inc.
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- October 16, 2020
- Completion date
- October 30, 2021
- Enrollment
- 67 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19, sars-cov-2